GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Classifica tra le azioni
#3629
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Prezzo delle azioni
$27.54
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$4.67B
Variazione (1 giorno)
-2.73%
Variazione (1 anno)
-11.86%
Paese
IN
Scambia GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Categoria
Healthcare
Storico del rendimento da dividendi per GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Il rendimento da dividendi (TTM) di GlaxoSmithKline Pharmaceuticals Limited (simbolo azionario: GLAXO) al 2024-03-31 è: 1.61%
Rendimento medio negli ultimi 5 anni: 2.91%
Rendimento medio negli ultimi 5 anni: 2.91%
Storico del rendimento da dividendi per GlaxoSmithKline Pharmaceuticals Limited (GLAXO) da 2004 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
| Anno | Rendimento da dividendi | Cambia |
|---|---|---|
| 2026 (TTM) | 2.28% | 44.30% |
| 2025 | 1.58% | -1.86% |
| 2024 | 1.61% | -76.32% |
| 2023 | 6.80% | 279.89% |
| 2022 | 1.79% | -35.38% |
| 2021 | 2.77% | 44.27% |
| 2020 | 1.92% | 42.22% |
| 2019 | 1.35% | -5.59% |
| 2018 | 1.43% | -21.43% |
| 2017 | 1.82% | 10.98% |
| 2016 | 1.64% | 40.17% |
| 2015 | 1.17% | -29.52% |
| 2013 | 1.66% | -19.42% |
| 2012 | 2.06% | 0.49% |
| 2011 | 2.05% | 60.16% |
| 2010 | 1.28% | -48.18% |
| 2009 | 2.47% | -20.58% |
| 2008 | 3.11% | 3.67% |
| 2007 | 3.00% | 25.00% |
| 2006 | 2.40% | 10.60% |
| 2005 | 2.17% | 65.65% |
| 2004 | 1.31% | 0.00% |
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
| Azienda | Rendimento da dividendi | Il paese |
|---|---|---|
| 0.55% |
US
|
|
| 2.08% |
US
|
|
| 2.44% |
US
|
|
| 2.31% |
US
|
|
| 2.69% |
CH
|
